Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Electro Optic Systems

    MCap

    AUD1,907m

    Last close

    AUD10.58

    ▲ 1.98 (23.02%)

    Metals One

    MCap

    —

    Last close

    GBP0.01

    ▲ 0.18 (19.44%)

    Circio Holding

    MCap

    NOK2,999m

    Last close

    NOK10.92

    ▲ 1.74 (18.95%)

  • Sectors

    Sectors

    View All Sectors
  • Megatrends

    Megatrends

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Sparks commentary - SynAct Pharma

Healthcare

Sparks - SynAct Pharma

More on this equity
SynAct Pharma (STO: SYNACT) – preclinical resomelagon data support use in osteoarthritis
Published by Arron Aatkar, PhD

SynAct Pharma has reported that some early preclinical data have shown that resomelagon may reduce inflammation and joint damage associated with osteoarthritis, and, hence, may reduce pain and improve quality of life for this patient population. While the current focus is in rheumatoid arthritis, these latest findings support the exploration of the drug candidate in this new indication. Further data are due to be presented at the 17th World Congress of Inflammation, to be held in Brazil, 8–12 September 2026.

Next Sparks Commentary in this sector >

Latest

Industrials | Comment

Metlen Energy & Metals (LSE: MTLN; ATHEX: MYTIL) – Proposed demerger of concessions and PPP activities

Healthcare | Comment

Mendus (OMX: IMMU) – CML momentum builds (Q226 results)

Healthcare | Comment

Herantis Pharma (HEL: HRTIS) – Phase II preparations take centre stage (H126 results)

Healthcare | Comment

SynAct Pharma’s (STO:SYNACT) Q226 results highlight resomelagon progress

Healthcare | Comment

Percheron Therapeutics (ASX:PER) FY26 results broadly in line, HMBD-002 in Focus
Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.